UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) Book value per share
UFP Technologies, Inc.'s book value per share at the end of fiscal 2025 was 55.0×, up 23.1% from 44.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 62.7×. Over the past ten years it has ranged from 14.6× (fiscal 2015) to 55.0× (fiscal 2025) — the current reading is the highest in ten years. UFP Technologies, Inc. ranks 5th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 55.0× | 23.07% |
| FY2024 | 44.7× | 19.12% |
| FY2023 | 37.5× | 19.49% |
| FY2022 | 31.4× | 21.52% |
| FY2021 | 25.8× | 9.34% |
| FY2020 | 23.6× | 8.32% |
| FY2019 | 21.8× | 14.14% |
| FY2018 | 19.1× | 12.01% |
| FY2017 | 17.1× | 8.55% |
| FY2016 | 15.7× | 7.82% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 62.7× | 4.96% |
| Jun 2026 | 59.7× | 5.11% |
| Mar 2026 | 56.8× | 3.32% |
| Dec 2025 | 55.0× | 5.04% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UFPT UFP Technologies, Inc. | 62.7× |
| INSP Inspire Medical Systems, Inc. compare | 28.6× |
| TMDX TransMedics Group, Inc. compare | 15.9× |
| NEOG Neogen Corporation compare | 9.6× |
| AXGN AxoGen, Inc. compare | 9.0× |
| ALMR Alamar Biosciences, Inc. compare | 4.4× |
| NVCR NovoCure Limited compare | 3.0× |
| ESTA Establishment Labs Holdings Inc. compare | 0.7× |
| BFLY Butterfly Network, Inc. compare | 0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement